5M PRODUCT
Icalute 50mg Bicalutimide tablets
Anticancer PHARMACEUTICAL PRODUCT

Icalute 50mg Bicalutimide tablets

Strength 50MG
Published by 5M Biotech India
Last updated 24 October 2026
Company Profile →
PRODUCT INFORMATION

About Icalute 50mg Bicalutimide tablets

Product information published by 5M Biotech India.

Active Ingredient Bicalutamide
Brand Icalute
Country of origin India
Form Oral Tablet

Icalute 50mg Tablet is a non-steroidal anti-cancer medicine used for the treatment of prostate cancer. It contains the active ingredient Bicalutamide that belongs to a group of medicines called anti-androgens. This medicine is used in men under medical supervision and is not recommended for use in females, children, or adolescents.

Clinical Uses

Icalute 50mg Tablet is used to treat advanced prostate cancer in men. It can be used in combination with luteinizing hormone-releasing hormone (LHRH) medicine or after surgical removal of the testicles.

How It Works

Icalute 50mg Tablet works by blocking the action of male hormones called androgens, especially testosterone. These hormones can help to grow the prostate cancer cells. The active ingredient Bicalutamide, blocks testosterone from attaching to prostate cancer cells. This action slows down the growth of the cells.

This medicine is usually used in combination with an LHRH analog. Together, these medicines reduce the testosterone level and block its effects on cancer cells. As a result, it may reduce prostate cancer growth.

Side Effects

Side effects of Icalute 50mg Tablet include:

  • Breast enlargement in men
  • Nausea
  • Vomiting
  • Abdominal pain
  • Breast tenderness
  • Constipation
  • Diarrhea
  • Weakness
  • Swelling in your ankles, legs, or feet
  • Dizziness
  • Anemia
  • Infection
  • Body pain

Consult your doctor if you experience any discomfort after taking this medicine to manage the symptom.

Precautions & Warnings

  • Icalute 50mg Tablet is not recommended during pregnancy. It can cause serious harm leading to birth defects or pregnancy loss. Inform your doctor if you are pregnant or planning to become pregnant.
  • Icalute 50 mg Tablet is unsafe for breastfeeding women. It may be toxic to the baby.
  • Driving is not safe while taking this medication, as it can cause dizziness or affect your vision.
  • Limit or avoid alcohol during the medication.
  • Inform your doctor if you have liver disease.
  • Patients with a history of diabetes mellitus should use this medicine with caution, as it can increase glucose levels in the blood.

Drug Interactions

Icalute 50 mg Tablet can interact with certain medications. Inform your doctor about any other medicines you are taking.

Some of the medicines that can interact with Icalute 50mg Tablet are:

  • Etrasimod
  • Pimozide
  • Methadone
  • Ozanimod
  • Lomitapide
  • Leflunomide
  • Quinidine
  • Thioridazine
  • Clozapine

Disclaimer

At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.

All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.

All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.

Publisher 5M Biotech India
Last Updated 24 October 2026
Product Record #647
Therapeutic Area Anticancer
PRODUCT ENQUIRY

Discuss Icalute 50mg Bicalutimide tablets